â??Safety study of Quista - Isolate in Healthy Adult Volunteers
- Registration Number
- CTRI/2020/09/028141
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Healthy adult volunteers of either sex aged between >=18 to <=50 years.
2. Subjects willing to sign informed consent and follow the study
procedure.
3. Has not participated in a similar investigation in the past four weeks.
4. Subjects willing to refrain taking any other nutritional supplement
during the study period
1. Subjects with clinically significant serious cardiovascular,
cerebrovascular, respiratory, liver,
renal disease, congenital or any other disorder.
2. A known history or present condition of allergic response to
pharmaceutical products its
components or ingredients in the test product.
3. Pre-existing systemic disease necessitating long-term
medications.
4. Genetic and endocrinal disorders.
5. Subjects who refused to sign informed consent.
6. Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method